2021 (became Septerna) Origin Story : Septerna is co-founded by Robert Lefkowitz, a Duke University biochemist who won the 2012 Nobel Prize in Chemistry for his work decoding G protein-coupled receptors (GPCRs)
Peter Sikiric, the peptide's principal investigator, has stated: "BPC-157 has demonstrated a remarkable safety profile across hundreds of experimental applications, with no observed lethal dose in any tested species and consistent organ-protective effects rather than organ-damaging ones" 1
Double blind, placebo controlled studies have shown promise for the ability of NAC to help alleviate depressive disorders
Generally, L-Cystine can be synthesized through three primary methods: 1
[17] [18] These reactions typically resolve within a few days without intervention
Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations, and studies in human tissues